
Next generation
full-body embolic
protection for TAVI


The European Commission Horizon 2020
Program Backs
Filterlex’s
Embolic Protection Device - CAPTIS
€2.1M Grant to support Filterlex’s CAPTIS clinical trials
FILTERLEX
THE NEED
During catheter-based, left-heart procedures such as TAVI, embolic particles are often released to the blood flow. Particles migration to the brain may cause a spectrum of neurological deficiencies, from cognitive impairment to debilitating stroke. Emboli released to distal organs may result in acute kidney injury and ischemia.
CAPTIS®
CAPTIS® UNIQUE BENEFITS

Full-body embolic protection

Embolic capture and extraction

Easy and intuitive deployment and retrieval

Aortic surface protection

Fully integrates with the procedure

No interference to procedure devices

Stable and safe anchoring

Very stable aortic arch deflector

Accommodates anatomical variations
NEWS
Sep 16 // 2019
€2.1M Grant to support Filterlex’s CAPTIS clinical trials
Best Innovation Award at the EuroPCR
May 6 // 2019
Filterlex receives the Best Innovation Award at the EuroPCR 2019 for the CAPTIS Embolic Protection Device for TAVI.

This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 881076

- info@filterlex.com
- Filterlex Medical Ltd, Ha-Otsma 1, Yokneam, Israel
filterlex 2019 © All rights reserved
face 2 face – web development